Regarding the loss of CD20 after rituximab therapy.
Ronald
R
Lee
Raul C
RC
Braylan
D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000187:drug effects*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D016477:Artifacts; D001667:Binding, Competitive; D006801:Humans; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000970:Antineoplastic Agents; D000069283:Rituximab